(UroToday.com). At the 2021 European Association of Urology annual meeting, Dr. Jacob Fredsoe presents the ProCaRis trial, which is a risk-adapted screening trial for prostate cancer utilizing single nucleotide polymorphisms (SNPs).
(UroToday.com). At the 2021 European Association of Urology annual meeting, Dr. Jacob Fredsoe presents the ProCaRis trial, which is a risk-adapted screening trial for prostate cancer utilizing single nucleotide polymorphisms (SNPs).